trial · primary record
ABSK121-NX
Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 169 |
| Primary completion | 2027-01-30 |
| Primary endpoint | Incidence of DLT |
| Registry ID | NCT05627063 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:38.242Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05627063
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.